Maria Hirsch
Family · Lubbock, TXNPI 1659892644
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $6,191 of the $7,358 with a category attached, or 84.1%. It is spread thinly across 34 manufacturers, the largest accounting for just 16.9% — the pattern of someone who eats at a lot of different presentations. Among family clinicians in TX with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 300 payments — averaging $24.53 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Abbott$1K
- Medtronic$694
- AbbVie$590
- Neurocrine Biosciences, Inc.$390
- AstraZeneca$333
- UCB, Inc.$315
- plus $4K from 28 others
What the payments were for
- Travel & lodging$1,16716%
- Food & beverage$6,19184%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Abbott | 11 | $1,243 |
| Medtronic | 43 | $694 |
| AbbVie | 36 | $590 |
| Neurocrine Biosciences, Inc. | 23 | $390 |
| AstraZeneca(2 entities) | 12 | $333 |
| UCB, Inc. | 16 | $315 |
| Merz Pharmaceuticals, LLC | 14 | $301 |
| TG Therapeutics, Inc. | 10 | $295 |
| Eisai Inc. | 13 | $291 |
| Argenx US, Inc. | 13 | $281 |
| EMD Serono, Inc. | 11 | $258 |
| Teva Pharmaceuticals USA, Inc. | 12 | $255 |
| Medical Device Business Services, Inc. | 1 | $222 |
| Lundbeck LLC | 12 | $219 |
| Lilly USA, LLC | 11 | $189 |
| Biosense Webster, Inc. | 2 | $177 |
| Biogen | 8 | $148 |
| Pfizer | 7 | $140 |
| Amneal Pharmaceuticals LLC | 7 | $123 |
| Averitas Pharma Inc. | 4 | $102 |
| Amgen | 5 | $102 |
| Novartis | 5 | $95 |
| SK Life Science, Inc. | 4 | $84 |
| Genentech USA, Inc. | 4 | $79 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 1 | $78 |
| Vanda Pharmaceuticals Inc. | 4 | $71 |
| Otsuka America Pharmaceutical, Inc. | 2 | $58 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $51 |
| Jazz Pharmaceuticals Inc. | 2 | $37 |
| Boston Scientific | 1 | $36 |
| CSL Behring | 1 | $33 |
| Johnson & Johnson | 1 | $26 |
| NS Pharma, Inc. | 1 | $22 |
| MDD US Operations, LLC | 1 | $18 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$7,358 in reported general payments places this provider in the 95th percentile of 15,456 family providers in Texas.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Memantine Hcl | 117 | $2,762 |
| Gabapentin | 140 | $2,206 |
| Lacosamide | 25 | $1,624 |
| Levetiracetam | 24 | $1,396 |
| Donepezil Hcl | 133 | $1,293 |
| Propranolol Hcl | 63 | $984 |
| Pregabalin | 75 | $944 |
| Topiramate | 48 | $890 |
| Amitriptyline Hcl | 74 | $862 |
| Carbidopa-LevodopaCarbidopa/Levodopa | 41 | $556 |
| RivastigmineRivastigmine Tartrate | 17 | $538 |
| Divalproex Sodium ErDivalproex Sodium | 36 | $530 |
| Tizanidine Hcl | 25 | $443 |
| Escitalopram Oxalate | 71 | $442 |
| Divalproex Sodium | 16 | $436 |
Paid to pharmacies, not to this prescriber.
Other family in Lubbock
- David WeirDallas$959K
- Robin BeachHouston$428K
- April LopezMcAllen$417K
- Sarah AguilarHouston$199K
- Sie ThomasDallas$197K
- Anna CastroSan Antonio$184K
- Jill CampbellShenandoah$182K
- Angela AchaPflugerville$174K
- Susan BowlinIrving$164K
- Stephanie RodriguezCorpus Christi$159K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.